Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Oxford University and Novo Nordisk have announced the establishment of an international postdoctoral fellowship programme to support research within the fields of diabetes, metabolism and endocrinology.

A total of 12 postdoctoral fellowships will be awarded, each for a 3 year period. The fellows will be hosted by Oxford University and funded by Novo Nordisk. The goal of the programme is to support the development of a new generation of research leaders while further developing scientific excellence within diabetes.

The programme will be coordinated through the Radcliffe Department of Medicine (RDM). The first four fellows in the programme will start in the autumn of 2014. Full details on the programme will be available shortly. Any queries should be directed to Dr Ruth McCaffrey.

The full text of the release is available.

We want to hear about your news!

Publishing a paper? Just won an award? Get in touch with communications@rdm.ox.ac.uk

 

Similar stories

Mechanism behind repair of cancer-inducing mutations discovered

New Nature paper uncovers the precise mechanism behind how the BRCA1 protein detects and engages with DNA breaks in the genome, helping to prevent the development of breast and ovarian cancers.

High blood sugar levels ‘reprogramme’ stem cells

Findings explain higher risk of heart attack in people with diabetes, even after treatment .

PTH infused insulin pump used as an alternative treatment for young patients with ADH1

Queen Mary University of London and OCDEM researchers develop alternative treatment for patients as young as three months.

Early blood-sugar levels in type 2 diabetes crucial for future prognosis

People who get type 2 diabetes need to gain control of their blood-sugar levels — fast. The years immediately after diagnosis are strikingly critical in terms of their future risk for heart attacks and death.